RxDoctor Payments DataLook up a doctor →

Gregory Bensch, MD

Allergy/ Immunology · Stockton, CANPI 1710950589

Payments from drug & device makers

$2,147,517in general payments, 2019–2025

Across 2,324 payments — averaging $924.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$713K
  • Sanofi$449K
  • AstraZeneca$365K
  • Teva Pharmaceuticals USA, Inc.$148K
  • Regeneron$85K
  • Incyte Corporation$68K
  • plus $319K from 36 others
$3,712in research payments, 2019–2025

Across 7 payments — averaging $530.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few allergy/ immunology providers in Californiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$534,103
Medicare patients
547
Services billed
28,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy/ immunology in Stockton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →